Bausch & Lomb IPO to be one of 2013's largest

Bausch & Lomb entertained acquisition offers, but has decided to pursue an initial public offering instead - a strategy in line with CEO Brent Saunders' assertion in January that the ophthalmology company likely would return to the public markets.